Shares of Nvidia Corp. are growing increasingly disconnected from the average stock in the S&P 500, prompting one analyst to quip that the chip designer is starting to behave like its own asset class.
U.K. pharmaceutical giant GSK said the deal gives it the rights to develop, manufacture and commercialize messenger RNA-based candidate vaccines for flu and COVID-19.
NeuroSense Therapeutics Ltd.’s stock rose 6.5% Tuesday, as analysts cheered data from the biotech’s late-stage trial of a treatment for the fatal disease amyotrophic lateral sclerosis, or ALS.